OXYCODONE Drug Patent Profile

Which patents cover Oxycodone, and when can generic versions of Oxycodone launch?

Oxycodone is a drug marketed by Bristol Myers Squibb, Actavis Elizabeth, Barr, Duramed Pharms Barr, Halsey, Mallinckrodt, Mutual Pharm, Vintage Pharms, Vintage Pharms Llc, Watson Labs, Abhai Llc, Mikart, Sankalp Lifecare, Specgx Llc, Alvogen, Amneal Pharms, Amneal Pharms Ny, Ascent Pharms Inc, Aurolife Pharma Llc, Chartwell, Dr Reddys Labs Sa, Elite Labs Inc, Epic Pharma Llc, Granules, Lannett Co Inc, Nesher Pharms, Novel Labs Inc, Ph Health, Rhodes Pharms, Sanaluz, Sun Pharm Inds Inc, Wes Pharma Inc, Actavis Labs Fl Inc, Ani Pharms, Sun Pharm Industries, Roxane, Avanthi Inc, Genus Lifesciences, Alkem Labs Ltd, Chartwell Molecular, Hibrow Hlthcare, Hikma, Pharm Assoc, Pharmobedient, Quagen, Vistapharm Llc, Nuvo Pharm, Strides Pharma Intl, and Barr Labs Inc. and is included in one hundred and eleven NDAs.

The generic ingredient in OXYCODONE is ibuprofen; oxycodone hydrochloride. There are sixty-four drug master file entries for this compound. Additional details are available on the ibuprofen; oxycodone hydrochloride profile page.

Summary for OXYCODONE

US Patents:	0
Applicants:	49
NDAs:	111
Drug Prices:	Drug price information for OXYCODONE
Drug Sales Revenues:	Drug sales revenues for OXYCODONE
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for OXYCODONE
DailyMed Link:	OXYCODONE at DailyMed

See drug prices for OXYCODONE

See drug sales revenues for OXYCODONE

Recent Clinical Trials for OXYCODONE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Baylor College of Medicine	PHASE1
Christopher D. Verrico	PHASE1
Region Skane	PHASE4

See all OXYCODONE clinical trials

Medical Subject Heading (MeSH) Categories for OXYCODONE

Analgesics, Opioid

Narcotics

Anatomical Therapeutic Chemical (ATC) Classes for OXYCODONE

N02AA	Natural opium alkaloids
N02A	OPIOIDS
N02	ANALGESICS
N	Nervous system

Paragraph IV (Patent) Challenges for OXYCODONE

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
XTAMPZA ER	Extended-release Capsules	oxycodone	9 mg, 13.5 mg, 18 mg, 27 mg and 36 mg	208090	1	2017-11-15

US Patents and Regulatory Information for OXYCODONE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mikart	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	040679-001	May 16, 2006		DISCN	No	No
Watson Labs	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	040535-002	Sep 5, 2003		DISCN	No	No
Aurolife Pharma Llc	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	201972-003	Jul 15, 2013	AA	RX	No	No
Amneal Pharms Ny	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	040778-001	Nov 27, 2007	AA	RX	No	No
Aurolife Pharma Llc	OXYCODONE HYDROCHLORIDE	oxycodone hydrochloride	TABLET;ORAL	202160-002	Nov 19, 2012	AB	RX	No	No
Amneal Pharms	OXYCODONE HYDROCHLORIDE	oxycodone hydrochloride	TABLET;ORAL	203638-002	Jun 3, 2014	AB	RX	No	No

DrugChatter Q&A for OXYCODONE

What withdrawal symptoms occur after long term oxycodone use?
How does oxycodone affect the body over time?
How does oxycodone use affect the liver long term?
Can you take oxycodone long term?
Can oxycodone cause kidney damage over time?